Eligibility Tool

Enter information for up to 5 patients in the fields below to determine their eligibility and get recommended dosing information. The tool queries a database of known mutations to Vertex, including cDNA names, legacy names, protein names, and known aliases.

Enter information for a patient in the fields below to determine their eligibility and get recommended dosing information. The tool queries a database of known mutations to Vertex, including cDNA names, legacy names, protein names, and known aliases.

Enter information for a patient in the fields below to determine their eligibility and get recommended dosing information. The tool queries a database of known mutations to Vertex, including cDNA names, legacy names, protein names, and known aliases.

Are your patients eligible for PRODUCT X?

Enter your patients’ mutations to see if they are eligible for PRODUCT X.
You may determine eligibility for up to 15 patients at once. PRODUCT X is indicated for patients ages 12 years and older.
1.
Mutation 1
(optional)
Mutation 2 (optional)
Age Selection
Mutation 1
(optional)
Mutation 2 (optional)
Age Selection
1.
Mutation 1
(optional)
Mutation 2 (optional)
Age Selection
Add Row
Duplicate Row

Mutation(s) not recognized. Please check to see if they were entered correctly.

DOB format not recognized. Please retry.

The provided DOB does not match any of the Age Ranges.

Expand
Collapse

    Learn how to enter 2 or more mutations


    Most patients have 1 CFTR mutation on each allele. However, in rare occasions, a single allele can have more than 1 mutation. This is called a compound, or complex, mutation.  

    To enter 2 or more mutations into 1 entry field, separate them with a semicolon, space, comma, or forward slash. For example, if your patient's genotype is R74W/V201M/D1270N and W1282R, use the Mutation 1 field to enter: R74W/V201M/D1270N, and Mutation 2 field to enter: W1282R.

    Vertex offers several cystic fibrosis (CF) treatment options for patients of certain ages with specific CF gene mutations. Not everyone with CF is eligible for a treatment option.

    This website features a list of treatment options that are currently available in the US from Vertex.